【摘要】 本组采用三氮唑核苷(病毒唑ribavirin)治疗流行性出血热低血压休克期的患者23例(男17例,女6例;年龄20-65yr,平均44±15yr),每日1g,疗程5d。结果:治疗组退热及血压稳定时间、少尿及多尿持续时间、尿蛋白消退及尿素氮(BUN)恢复正常时间均较对照组短(P<0.05),且未见明显副作用。更多还原

【Abstract】 Twenty-three patients (17M, 6F, age 20-65yr, 44±15yr) of hypotensive shock stage of epidemic hemorrhagic fever were treated with intravenous infusion of ribavirin 1g daily for 5 d. Nineteen patients served as control. The results showed that defervescence, to attain stable period of blood pressure, periods of oliguria and polyuria, disappearance of proteinuria and recovery of BUN to normal level were all significantly shorter than the control group, No serious adverse reactions were observed.更多还原